New regulatory announcements can quickly change which stocks feel comfortable to hold and which ones start to look more exposed. The latest round of policy updates is already reshaping expectations for sectors where rules, compliance costs, and oversight sit at the heart of the business model. For investors trying to pick their spots carefully, understanding where regulatory risk might squeeze margins or limit growth plans is just as important as tracking earnings. This article walks through 3 stocks that appear more vulnerable to the recent news and explains why some investors may choose to tread carefully around them.

Morgan Stanley (MS)

Overview: Morgan Stanley is a global financial holding company that helps corporations, governments, institutions, and individuals raise capital, manage wealth, invest, and borrow, through its Institutional Securities, Wealth Management, and Investment Management businesses across the Americas, Europe, the Middle East, Africa, and Asia.

Operations: Morgan Stanley generates most of its US$103.2b revenue from Institutional Securities at US$34.5b and Wealth Management at US$32.9b, with Investment Management contributing US$6.5b and the Americas accounting for US$54.4b of total revenue.

Market Cap: US$352.0b

Morgan Stanley might catch your eye for its mix of wealth management ambitions and global capital markets reach. However, the current regulatory backdrop makes the story more fragile than it looks at first glance. Heavier rules can lift compliance costs and constrain balance sheet flexibility, which matters for a firm that relies entirely on external funding and carries a relatively low 15.9% ROE alongside a dividend that is not well covered by free cash flow. When adding in high non cash earnings, recent insider selling, and growing scrutiny of AI use in banking, the risk side of the ledger grows quickly. At the same time, the company is still pricing in a lot of optimism, which leaves limited room for disappointment if regulation becomes more restrictive.

Morgan Stanley’s mix of external funding, thin dividend cover, and higher compliance costs could be masking where the real pressure lands next, so review the 3 key rewards and 3 important warning signs (1 is major!)

UnitedHealth Group (UNH)

Overview: UnitedHealth Group is a large US health care company that combines a global health insurance business with a broad services platform, offering medical benefits, data and analytics, clinical care, and pharmacy services to employers, governments, and individuals.

Operations: UnitedHealth Group reports most of its revenue from UnitedHealthcare at US$346.6b and Optum Rx at US$155.3b, with Optum Health contributing US$101.2b and Optum Insight US$19.5b, partly offset by corporate and segment adjustments.

Market Cap: US$364.1b

UnitedHealth Group might look appealing thanks to its large scale, deep reach across Medicare and Medicaid, and efforts to use technology and value based care programs to improve margins. However, the picture is more fragile when regulatory risk is front and center. Earnings have been under pressure, with margins at 2.7% and earnings declining over recent years, while the company carries high debt and relies entirely on external funding. At the same time, the stock is trading well below one DCF based fair value estimate. Expectations are already complicated by mixed analyst views, legal disputes around Medicaid, and fresh rules that could reshape reimbursement and costs. Investors who assume this is a straightforward defensive healthcare giant may be missing several pressure points that matter in a tougher rule book.

UnitedHealth Group’s thin 2.7% margins, earnings pressure, and regulatory overhang suggest the real story may be in what is not priced in yet. Review the 3 key rewards and 2 important warning signs

Goldman Sachs Group (GS)

Overview: Goldman Sachs Group is a global financial institution that advises companies and governments on deals, raises equity and debt, trades markets, and manages money for institutions and wealthy individuals. It also offers credit cards and cash management services through its newer platforms.

Operations: Goldman Sachs Group generates most of its US$61.5b revenue from Global Banking & Markets at US$42.9b and Asset & Wealth Management at US$17.1b, with Platform Solutions contributing US$1.5b and the Americas accounting for US$37.1b of total revenue.

Market Cap: US$336.2b

Goldman Sachs Group sits at the center of dealmaking, AI related IPO flow, and asset management. However, the picture is less comfortable when you layer in aggressive regulatory change, higher funding risk, and mixed growth signals. The company has profit margins around 27.7%, but no customer deposits and 100% external funding leave it more exposed if capital and liquidity rules tighten or credit spreads widen. Forecast revenue and earnings growth are described as modest, dividend cover by free cash flow is weak, and analysts already describe pricing as fair against their targets. In addition, recent insider selling, regulatory scrutiny of AI in finance, and new rules that could weigh on capital markets activity mean this is a stock where investors may want to understand the full risk profile before becoming too confident.

Goldman Sachs Group’s pricing may look fair on the surface, but 100% external funding and tighter rules could be masking where the real strain hits next. Walk through the full risk story in the analysis report for Goldman Sachs Group

Take Control of Your Investment Journey

If Morgan Stanley or any of these companies are making you feel more cautious, register for FREE with Simply Wall St and add your companies to a Watchlist to monitor the share price against the fair value and track any new developments as they happen. Once you've made your move, manage your holdings with our Portfolio Command Center that filters out the noise to deliver only the most critical, actionable updates. Throughout your journey, our Community allows you to filter the best ideas from thousands of investor perspectives. By uncovering hidden catalysts and risks early, you'll accelerate your decision-making and stay one step ahead of the market.

Seeking Alternatives Before Momentum Flies Past?

Fresh breakouts and quiet pullbacks rarely stay under the radar for long, and first-mover information decays fast. Scan these themed shortlists while it still matters and consider your options promptly.

• Identify cash rich businesses that may be better positioned to handle tougher rules by reviewing the curated list of solid balance sheet and fundamentals (48 results) before others catch on.
• Explore future facing infrastructure as power demand shifts by checking the hand picked 34 power grid technology and infrastructure stocks while prices and momentum still look workable.
• Monitor structural shifts in automation by scanning the tightly filtered 31 robotics and automation stocks before institutional activity potentially turns these under the radar moves into more crowded trades.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.